Delivery Order SPE2DB24D2100-SPE2DB25FBGQM
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Isosulfan Blue 1% vials (5ml) with a ceiling value of $30,946.99. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order operates...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Isosulfan Blue 1% Vial 5ML, a medical product, with a ceiling value of $14,667.86 and a period of performance through March 26, 2025. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,371.77 firm-fixed-price delivery order is for the supply of Isosulfan Blue 1% Vial 5mL, a medical product used in various medical procedures. The contract has an ultimate completion date of October 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty thousand one hundred eighty-five dollars and ninety-six cents ($30,185.96) to Amerisourcebergen Drug Corporation for 4561971256 Isosulfan Blue 1% Vial 5mL. The place of performance is Conshohocken, Pennsylvania. The order period of performance is from August 28, 2023 through August 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the...
- This federal contract award, valued at $14,509.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Isosulfan Blue 1% Vial, 5mL, a medical product used in various healthcare applications. The contract has an ultimate completion date of September 27, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant...
- The Defense Logistics Agency (DLA) awarded a $7,356.52 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4,566,185,907 units of 1% isosulfan blue dye vials (5 ml). This delivery order is a part of a larger indefinite delivery contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $81,127.55, is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML, a medical supply product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,797.44 firm-fixed-price delivery order is for the supply of ISOSULFAN BLUE 1% VIAL 5ML, a pharmaceutical product, with a completion date of May 11, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML medical supplies. The contract, valued at $17,431.82, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a completion date of January 5, 2024, and it is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,089.24 to AmerisourceBergen Drug Corp for the supply of Indocyanine Green 25 mg vials. The contract was competitively awarded without a set-aside designation and operates under a firm fixed-price structure with a delivery completion date of June 3, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as the place of performance for this medical supply delivery order. This delivery...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGQMDelivery Order
The Defense Logistics Agency awarded a $35.5K delivery order to AmerisourceBergen Drug Corp for Isosulfan Blue 1% in 5mL vials, with a completion date of September 25, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The product will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Isosulfan Blue is a vital diagnostic pharmaceutical used primarily in surgical procedures for lymphatic mapping and sentinel lymph node identification in cancer and other surgical applications. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive federal contract portfolio with the Defense Logistics Agency to supply comprehensive medical commodities, including specialty medications, vaccines, and diagnostic agents, to support military healthcare systems and other federal medical supply chains. This delivery order exemplifies the company's ongoing role as a critical vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.5k | 9/24/25 |